Canopy Growth Corporation (CGC) Stock Analysis & Winston Score
Canopy Growth Corporation is a Canadian cannabis company that grows, packages, and sells marijuana and hemp products. Its main products include dried cannabis flower, oils, edibles, and beverages sold under brands like Tweed and Storz & Bickel vaporizers. It sells to adult recreational users and medical patients, primarily in Canada, with some operations in Germany and the United States hemp market. The company makes money by selling cannabis products directly to government-run stores in Canada and through medical channels in other countries. With a market cap of around $400 million, Canopy Growth is one of the larger cannabis companies, but it has struggled to turn a profit, posting negative operating margins. The biggest risk the company faces is continued cash burn — it has lost money for years — while the key growth opportunity depends on whether the U.S. federal government eventually loosens restrictions on cannabis, which would open a much larger market.
Winston Score: 16/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (2/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Good (8/15)
Key Facts
Price: $0.94
Market Cap: $397M
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: NASDAQ
